Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The oncologic four-minute mile

B A Chabner

    The Oncologist
    |June 26, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cytidine and deoxycytidylate deaminase inhibition by uridine analogs.

    Biochemical pharmacology·2010
    Same author

    Complementary, alternative, integrative, or unconventional medicine?

    The oncologist·2001
    Same author

    Losing God.

    The oncologist·2001
    Same author

    Caring for colleagues.

    The oncologist·2001
    Same author

    Medical mistakes: a workshop on personal perspectives.

    The oncologist·2001
    Same author

    On receptor inhibitors and chemotherapy.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2001
    Same journal

    Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

    The oncologist·2026
    Same journal

    Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

    The oncologist·2026
    Same journal

    Modernizing Disease Assessment in Prostate Cancer Trials: The Prostate Cancer Working Group 4 Framework.

    The oncologist·2026
    Same journal

    Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.

    The oncologist·2026
    Same journal

    Dose-Expansion Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors.

    The oncologist·2026
    Same journal

    Comparison of Allo-HSCT outcomes after CAR-T therapy versus chemotherapy in pediatric patients with relapsed/refractory B-ALL: a retrospective study.

    The oncologist·2026
    See all related articles